» Articles » PMID: 31361345

Therapeutic Strategies for Targeting Telomerase in Cancer

Overview
Journal Med Res Rev
Publisher Wiley
Date 2019 Jul 31
PMID 31361345
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Telomere and telomerase play important roles in abnormal cell proliferation, metastasis, stem cell maintenance, and immortalization in various cancers. Therefore, designing of drugs targeting telomerase and telomere is of great significance. Over the past two decades, considerable knowledge regarding telomere and telomerase has been accumulated, which provides theoretical support for the design of therapeutic strategies such as telomere elongation. Therefore, the development of telomere-based therapies such as nucleoside analogs, non-nucleoside small molecules, antisense technology, ribozymes, and dominant negative human telomerase reverse transcriptase are being prioritized for eradicating a majority of tumors. While the benefits of telomere-based therapies are obvious, there is a need to address the limitations of various therapeutic strategies to improve the possibility of clinical applications. In this study, current knowledge of telomere and telomerase is discussed, and therapeutic strategies based on recent research are reviewed.

Citing Articles

Telomeres, telomerase, and cancer: mechanisms, biomarkers, and therapeutics.

Shou S, Maolan A, Zhang D, Jiang X, Liu F, Li Y Exp Hematol Oncol. 2025; 14(1):8.

PMID: 39871386 PMC: 11771031. DOI: 10.1186/s40164-025-00597-9.


BIBR1532 inhibits proliferation and metastasis of esophageal squamous cancer cells by inducing telomere dysregulation.

Wang Q, Li Q, Xu L, Yuan Z, Liu X, Tang M World J Gastrointest Oncol. 2025; 17(1):99376.

PMID: 39817136 PMC: 11664625. DOI: 10.4251/wjgo.v17.i1.99376.


PinX1 suppresses cancer progression by inhibiting telomerase activity in cervical squamous cell carcinoma and endocervical adenocarcinoma.

Weng Y, Yan X, Chen B, Bian Z, Ge Y, Lu H Genes Dis. 2024; 12(2):101319.

PMID: 39634130 PMC: 11615109. DOI: 10.1016/j.gendis.2024.101319.


Preparation and anticancer activity of telomerase inhibitor TAT-LPTS39 polypeptide.

Zhang X, Zhang H, Feng J, Tang X, Zhao M, Chen G Transl Cancer Res. 2024; 13(9):4625-4638.

PMID: 39430831 PMC: 11483468. DOI: 10.21037/tcr-24-792.


Small Molecules Blocking the Assembly of TCAB1 and Telomerase Complexes: Lead Discovery and Biological Activity.

Zuo H, Ru Y, Gao X, Chen H, Yan Y, Ma X ACS Med Chem Lett. 2024; 15(8):1205-1212.

PMID: 39140071 PMC: 11318020. DOI: 10.1021/acsmedchemlett.4c00310.